Blue Fin Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.46M | Buy |
+13,603
| New | +$1.46M | 0.25% | 63 |
|
2024
Q4 | $979K | Buy |
10,963
+550
| +5% | +$49.1K | 0.18% | 75 |
|
2024
Q3 | $873K | Buy |
10,413
+406
| +4% | +$34K | 0.17% | 81 |
|
2024
Q2 | $771K | Buy |
10,007
+1,419
| +17% | +$109K | 0.15% | 81 |
|
2024
Q1 | $588K | Buy |
8,588
+706
| +9% | +$48.4K | 0.13% | 89 |
|
2023
Q4 | $456K | Sell |
7,882
-142
| -2% | -$8.21K | 0.12% | 93 |
|
2023
Q3 | $424K | Buy |
8,024
+1,334
| +20% | +$70.4K | 0.12% | 94 |
|
2023
Q2 | $362K | Hold |
6,690
| – | – | 0.1% | 107 |
|
2023
Q1 | $347K | Hold |
6,690
| – | – | 0.11% | 105 |
|
2022
Q4 | $310K | Hold |
6,690
| – | – | 0.11% | 108 |
|
2022
Q3 | $259K | Sell |
6,690
-122
| -2% | -$4.72K | 0.1% | 111 |
|
2022
Q2 | $253K | Hold |
6,812
| – | – | 0.09% | 116 |
|
2022
Q1 | $301K | Sell |
6,812
-55
| -0.8% | -$2.43K | 0.09% | 113 |
|
2021
Q4 | $291K | Sell |
6,867
-171
| -2% | -$7.25K | 0.08% | 116 |
|
2021
Q3 | $305K | Sell |
7,038
-316
| -4% | -$13.7K | 0.09% | 103 |
|
2021
Q2 | $314K | Sell |
7,354
-321
| -4% | -$13.7K | 0.1% | 98 |
|
2021
Q1 | $296K | Sell |
7,675
-422
| -5% | -$16.3K | 0.1% | 101 |
|
2020
Q4 | $291K | Sell |
8,097
-672
| -8% | -$24.2K | 0.1% | 97 |
|
2020
Q3 | $335K | Buy |
8,769
+661
| +8% | +$25.3K | 0.14% | 90 |
|
2020
Q2 | $284K | Buy |
8,108
+646
| +9% | +$22.6K | 0.13% | 94 |
|
2020
Q1 | $243K | Buy |
7,462
+300
| +4% | +$9.77K | 0.13% | 102 |
|
2019
Q4 | $322K | Buy |
7,162
+656
| +10% | +$29.5K | 0.15% | 108 |
|
2019
Q3 | $264K | Sell |
6,506
-278
| -4% | -$11.3K | 0.14% | 110 |
|
2019
Q2 | $291K | Buy |
6,784
+431
| +7% | +$18.5K | 0.15% | 110 |
|
2019
Q1 | $243K | Buy |
+6,353
| New | +$243K | 0.13% | 118 |
|
2014
Q2 | – | Sell |
-16,600
| Closed | -$224K | – | 130 |
|
2014
Q1 | $224K | Sell |
16,600
-875
| -5% | -$11.8K | 0.2% | 110 |
|
2013
Q4 | $210K | Buy |
+17,475
| New | +$210K | 0.19% | 114 |
|